Oxygen Toxicity in the Resuscitation in Extremely Premature Infants (OXTOX)

This study has been completed.
Sponsor:
Collaborator:
Instituto de Salud Carlos III
Information provided by:
Fundacion Para La Investigacion Hospital La Fe
ClinicalTrials.gov Identifier:
NCT00494702
First received: June 28, 2007
Last updated: October 14, 2008
Last verified: October 2008

June 28, 2007
October 14, 2008
April 2005
March 2008   (final data collection date for primary outcome measure)
Achievement of a targeted saturation of 85% at 15 min of life. [ Time Frame: 30 min ] [ Designated as safety issue: Yes ]
Achievement of a targeted saturation of 85% at 15 min of life. [ Time Frame: 30 min ]
Complete list of historical versions of study NCT00494702 on ClinicalTrials.gov Archive Site
  • Neonatal mortality [ Time Frame: 28 days of life ] [ Designated as safety issue: No ]
  • Oxidative stress [ Time Frame: at day 1, 2 and 7 ] [ Designated as safety issue: No ]
  • Bronchopulmonary dysplasia [ Time Frame: 36 weeks postconceptional age ] [ Designated as safety issue: No ]
  • Retinopathy of prematurity [ Time Frame: 40 weeks postconceptional ] [ Designated as safety issue: No ]
  • Neurodevelopment [ Time Frame: 24 months postnatal ] [ Designated as safety issue: No ]
  • Neonatal mortality [ Time Frame: 28 days of life ]
  • Oxidative stress [ Time Frame: at day 1, 2 and 7 ]
  • Bronchopulmonary dysplasia [ Time Frame: 36 weeks postconceptional age ]
  • Retinopathy of prematurity [ Time Frame: 40 weeks postconceptional ]
  • Neurodevelopment [ Time Frame: 24 months postnatal ]
Not Provided
Not Provided
 
Oxygen Toxicity in the Resuscitation in Extremely Premature Infants
Achievement of a Targeted Saturation in Extremely Low Gestational Age Neonates Resuscitated With Low or High Oxygen Concentration: A Prospective Randomized Trial

The investigators hypothesize that using low oxygen concentrations during resuscitation of extremely premature infants will avoid oxidative stress derived damage and improve outcome.

This is a prospective randomized trial enrolling premature infants of less than 28 weeks gestation. Patients are randomly assigned to become resuscitation with an initial oxygen inspiratory fraction (FiO2) of 30% or 90%. Main objective is to reach a target saturation of 85% at 15 min of life.

Immediately after birth pre-and-postductal pulse oximeters are set and oxygen saturation (SpO2) continuously monitored and registered as long as the patient requires oxygen supplementation. FiO2 is stepwise adjusted (increased or decreased 10%) every 90 sec according to heart rate, SpO2 and responsiveness.

Blood samples are drawn from umbilical cord and at day 1, 2 and 7 from peripheral vein to determine oxidative stress markers (GSH, GSSG), angiogenic factors (VEGF, VEGF receptors, Angiopoietin), pro-inflammatory markers (IL8, TNF alfa) and pro-apoptotic markers (Fas Ligand; Cytochrome C).

Urine is collected every day during the first week of life to determine oxidative stress markers (8-oxo-dG; O-tyrosine; F2 isoprostanes; Isofurans).

Babies are followed in the NICU and clinical condition recorded. Serial examinations for ROP and Auditory evoked potentials will be performed. Neurodevelopmental outcome is evaluated at 2 years of postnatal life. Main outcome: Achievement of a target saturation of 85% at 15 min of life. Secondary outcomes: acute complications during delivery; chronic complications (BPD, ROP, IPVH); mortality in the neonatal period.

Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
  • Birth Asphyxia
  • Premature Birth
  • Procedure: Resuscitation
    Use of inspiratory fraction of oxygen needed to achieve oxygen saturation in the preset limits 85-88%
  • Procedure: Resuscitation
    Oxygen inspiratory fraction needed to keep oxygen saturation in the preset limits of 90-93%
  • Experimental: LOX
    Low saturation group of premature infants that will be kept within preset limits of 85-89%
    Intervention: Procedure: Resuscitation
  • Active Comparator: HOX
    HOX group of premature infants will be kept within preset saturation limits of 90-93%
    Intervention: Procedure: Resuscitation

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
88
September 2008
March 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Prematurity of less than 28 weeks gestation

Exclusion Criteria:

  • Severe malformations
  • Chromosomopathies
  • Informed consent not signed
Both
up to 3 Minutes
No
Contact information is only displayed when the study is recruiting subjects
Spain
 
NCT00494702
PIO51O5, FISPI05105
Yes
INSTITUTO DE SALUD CARLOS III -MINISTERIO DE SANIDAD Y CONSUMO -SPAIN, MAXIMO VENTO
Fundacion Para La Investigacion Hospital La Fe
Instituto de Salud Carlos III
Principal Investigator: Maximo Vento, Phd, Md Hospital Universitario La Fe
Fundacion Para La Investigacion Hospital La Fe
October 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP